<i><scp>LTBP4</scp></i> genotype predicts age of ambulatory loss in duchenne muscular dystrophy
Kevin M. Flanigan(Nationwide Children's Hospital), Robert B. Weiss(University of Utah), Alan Pestronk(Washington University in St. Louis), Eduard Gappmaier(University of Utah), Michael Howard(University of Utah), Yuuki Kaminoh(Nationwide Children's Hospital), Katherine D. Mathews(University of Iowa), Craig M. McDonald(University of California Davis Medical Center), Kathryn J. Swoboda(Massachusetts General Hospital), Richard S. Finkel(St. Jude Children's Research Hospital), Elizabeth M. McNally(Northwestern University), Jerry R. Mendell(Nationwide Children's Hospital), Julaine Florence, Diane M. Dunn(University of Utah), Kay‐Marie Lamar(University of Chicago), Wendy King(The Ohio State University), Ermelinda Ceco(Northwestern University)
Cited by 242
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
|The Lancet Neurology|2009|2k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
|The Lancet Neurology|2009|1.2k
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793